Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$325,896
+$76,070 QoQ
Shares Held
6,798
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#859
of 1,348 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRB Wealth Management, LLC holds $11,666,923 across 10 Drug Manufacturers - General names. NVO ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,820 | $3,382,392 | |
| 2 | JNJ |
Johnson & Johnson
|
10,921 | $2,773,606 | |
| 3 | ABBV |
AbbVie Inc.
|
7,827 | $1,969,586 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,434 | $955,269 | |
| 5 | AMGN |
Amgen Inc
|
1,725 | $624,657 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4,540 | $573,583 | |
| 7 | PFE |
Pfizer Inc
|
23,389 | $563,207 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
6,798 | $325,896 |
All Filings in NVO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $325,896 | 6,798 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $249,826 | 6,798 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||